Screening

In September 2026, the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) is working on 23 projects, including several Med Tech-related assessments concerning the diagnosis of endometriosis, newborn screening, and allergy diagnostic tests.

In June 2026, the National Institute for Health and Care Research (NIHR) in England released four Med Tech-related assessments in its HTA Journal, which concerned newborn screening for severe combined immunodeficiency, primary endovascular revascularization procedures for chronic limb-threatening ischemia, placental growth factor (PLGF)-based testing for suspected pre-eclampsia, and digital front door technologies before assessment for NHS Talking Therapies.

The UK National Screening Committee (UK NSC) will launch the 2026 open call for topics on July 1. Proposals may be submitted until September 30, 2026. The UK NSC conducts calls for topics every two years. Proposals may relate to new screening topics, updates to previously considered topics, or changes to existing screening programmes.

On June 9, 2026, the Swiss Federal Office of Public Health published changes to the Healthcare Benefit Ordinance (KLV/OPre), which determines coverage of medical services in Switzerland. The nearest changes will take effect on July 1, 2026, and include the introduction of the first-trimester preeclampsia screening and adjustment of the tariffs for the highest-grossing laboratory analyses (Annex 3 KLV), changes in reimbursement conditions for medical aids via the List of Medical Aids MiGel (Annex 2 KLV), as well as the expansion of the outpatient-before-inpatient policy (Annex 1a KLV) and update of coverage decisions on the List of explicitly evaluated services (Annex 1 KLV).

On April 20, 2026, the Common Package of Benefits of the Spanish National Health System was amended (by Order SND/356/2026, of April 13, 2026). The key changes relate to diagnostic imaging, in-vitro diagnostics, obstetrics and gynecology, and some other fields.

On April 9, 2026, the Spanish Network of HTA Agencies (RedETS) published the 2026 working plan for health technology assessments. The plan includes a wide range of topics in cardiovascular, dermatology, diagnostic imaging, e-health, endocrine, endoscopy, gastrointestinal, ICU/OR, in-vitro diagnostics, neurology and neurosurgery, neuromodulation, ophthalmology, radiology, robotic surgery, and some other fields.

In March 2026, the National Institute for Health and Care Research (NIHR) in England released five Med Tech-related assessments in its HTA Journal, which concerned eye screening programs in diabetes, surgical and non-surgical splint treatment for finger fractures, diagnostic strategies for ovarian cancer, biomarkers for outcomes prediction in adults with suspected sepsis, and diagnostic tools of peripheral arterial disease in diabetes.

On April 1, 2026, the revised EBM (German Uniform Evaluation Standard) catalog for the second quarter of 2026 came into force. The EBM catalog is used to reimburse day case and outpatient services under the fee-for-service model. The key changes include the introduction of new EBM codes for the reimbursement of lung cancer screening, monitoring progress, and evaluating the digital health application, as well as several IVD tests

In April 2026, the Canary Islands Healthcare Evaluation Service is working on several HTAs, including evaluations in e-health, IVD, neuromodulation, obstetrics and gynecology, and some other fields.

In March 2026, the Galician Agency for Health Technology Assessment (Avalia-t) is working on several HTAs, including in cardiovascular, dermatology, e-health, gastrointestinal, interventional radiology, robotic surgery, in-vitro diagnostics, peripheral vascular, neurology and neurosurgery, neuromodulation, and some other fields.

On January 30, 2026, the Federal Ministry of Labor, Social Affairs, Health, Care and Consumer Protection (BMASGPK) and Gesundheit Österreich GmbH (GÖG) jointly presented the National Cancer Framework Program 2026-2035. It serves as a strategic compass, setting the direction for cancer control and care in Austria over the next ten years, although it is not legally binding. The Program comprises four areas of action, 22 objectives, and 113 measures.

In December 2025, the National Institute for Health and Care Research (NIHR) in England released three Med Tech-related assessments in its HTA Journal, which concerned endoscopic treatments for obesity, whole-genome sequencing for rare diseases in newborn screening, and a tele-ophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease.